Repository logo
 

Quantitative Profiling of Nanoscopic Protein Aggregates Reveals Specific Fingerprint of TDP-43-Positive Assemblies in Motor Neuron Disease.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Abnormal aggregation of TAR DNA-binding protein 43 (TDP-43) is a pathological hallmark of motor neuron disease (MND), yet current methods for quantifying these aggregates in biological samples remain limited in sensitivity and resolution. Here, single-molecule fluorescence microscopy is applied to post-mortem brain extracts to quantitatively characterize aggregates containing TDP-43 at the individual particle level. The resulting aggregate fingerprints, consisting of morphological and compositional profiles, are sufficient to distinguish MND donors from neurologically normal controls and further discriminate between clinically distinct MND subgroups. Comparative proteomic analysis confirms and extends these findings, revealing convergent and complementary molecular signatures. These results demonstrate, for the first time, that single-molecule aggregate profiling can stratify MND cases using patient-derived tissues, paving the way for the development of sensitive minimally invasive diagnostics and mechanistically informed disease monitoring tools.

Description

Publication status: Published

Journal Title

Adv Sci (Weinh)

Conference Name

Journal ISSN

2198-3844
2198-3844

Volume Title

Publisher

Wiley

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
Royal Society (RSRP\R\210003)
This work was supported by the UK Dementia Research Institute, which receives its funding from DRI Ltd., funded by the UK Medical Research Council, Alzheimer's Society, and Alzheimer's Research. We would also like to acknowledge the support of the UK Dementia Research Institute Proteomics Platform, led by Dr Bethany Geary, and technical support in the form of reagents provided by Dr Yu P. Zhang (University of Cambridge). D.C. was supported by the Lady Edith Wolfson Junior Non‐Clinical Research Fellowship awarded by the MND Association UK (Cox 971‐799). JS was supported by a Wellcome Trust Senior Research Fellowship (221824/Z/20/Z). MAW was supported by an Alzheimer’s Research UK Research Fellowship (ARUK-RF2020A-008), an award from The Sean M. Healey & AMG Center for ALS at Mass General and ALS FindingACure, and the Rosetrees Trust (CF2\100004). EL was supported by a grant from Parkinson’s UK (G-1901).